Latest Articles

This article explores the relationship between the immune system and cancer and outlines therapeutic strategies that leverage a patient’s immune system to treat cancer.

Nine scientists from academia and industry offer their take on the crucial skills tomorrow’s scientists will need to thrive in an evolving research landscape, from AI to digital lab fluency.

Technology Networks recently had the pleasure of interviewing Dr. Tyler Brown, founder, president and chair of OUTbio San Diego, to learn more about the organization’s origins, rapid growth and mission to create lasting impact.

The article explores the importance of host cell protein analysis in biologics manufacturing, detailing challenges in detection, evolving analytical methods and increasing regulatory expectations.

This article explores how AI is transforming precision medicine by streamlining drug discovery, improving patient stratification and treatment prediction, and accelerating clinical trials while highlighting challenges around data quality.

Learn more about the effects US pharmaceutical tariffs could have on European companies and their strategies for overcoming cost and supply chain challenges.

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based approaches, highlighting their expanding clinical use, underlying mechanisms and the challenges that lie ahead.

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto Watamura could be vital.

Discover the latest in cystic fibrosis treatment, from CFTR modulators to ENaC blockers and emerging inhalable gene therapies.

Presenting at Technology Networks’ Cell and Gene Therapy 2025 Symposium, Dr. Andrew Mancini, senior corporate development manager at MaxCyte, shared his insights on how engineered cell therapies have evolved over the past eight years.